P2RY12 and Alzheimer disease: Middle and late MARPs reveal a decrease of microglial homeostatic functions affecting chemotaxis, cell migration and phagocytosis (e.g., CX3CR1, SYK, P2RY12, BIN2, TFEB and TFE3) and thus mark AD progression.